Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Norwalk virus | 13 | 2016 | 115 | 1.730 |
Why?
|
| Rotavirus | 12 | 2015 | 366 | 1.360 |
Why?
|
| Norovirus | 8 | 2024 | 288 | 1.150 |
Why?
|
| Gastroenteritis | 10 | 2016 | 307 | 0.810 |
Why?
|
| Caliciviridae Infections | 8 | 2024 | 289 | 0.720 |
Why?
|
| Polysaccharides | 4 | 2015 | 143 | 0.710 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2015 | 140 | 0.680 |
Why?
|
| Receptors, Virus | 4 | 2015 | 97 | 0.660 |
Why?
|
| Capsid Proteins | 3 | 2014 | 150 | 0.490 |
Why?
|
| Virus Replication | 6 | 2024 | 599 | 0.460 |
Why?
|
| Toxins, Biological | 1 | 2014 | 40 | 0.420 |
Why?
|
| Protein Multimerization | 1 | 2014 | 150 | 0.410 |
Why?
|
| Glycoproteins | 1 | 2014 | 348 | 0.370 |
Why?
|
| Antigens, Viral | 5 | 2014 | 395 | 0.290 |
Why?
|
| Dendritic Cells | 1 | 2010 | 437 | 0.260 |
Why?
|
| Capsid | 2 | 2000 | 96 | 0.250 |
Why?
|
| Macrophages | 1 | 2010 | 663 | 0.240 |
Why?
|
| Blood Group Antigens | 2 | 2016 | 65 | 0.240 |
Why?
|
| Rotavirus Infections | 5 | 2015 | 281 | 0.220 |
Why?
|
| RNA-Binding Proteins | 3 | 2014 | 552 | 0.210 |
Why?
|
| Species Specificity | 3 | 2015 | 496 | 0.200 |
Why?
|
| Viral Vaccines | 4 | 2000 | 316 | 0.190 |
Why?
|
| Viral Proteins | 4 | 2016 | 339 | 0.190 |
Why?
|
| Immunoglobulin A | 4 | 2016 | 208 | 0.190 |
Why?
|
| Diarrhea | 2 | 2015 | 313 | 0.180 |
Why?
|
| Virion | 3 | 1999 | 116 | 0.170 |
Why?
|
| Milk, Human | 2 | 2014 | 318 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 5 | 2014 | 719 | 0.170 |
Why?
|
| RNA, Viral | 6 | 2024 | 512 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2016 | 792 | 0.150 |
Why?
|
| Protein Binding | 4 | 2014 | 1674 | 0.130 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 2422 | 0.130 |
Why?
|
| Feces | 4 | 2015 | 725 | 0.130 |
Why?
|
| Neutralization Tests | 2 | 2016 | 226 | 0.130 |
Why?
|
| Vaccines, DNA | 1 | 1997 | 45 | 0.130 |
Why?
|
| Antibodies, Blocking | 1 | 2016 | 47 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2014 | 734 | 0.120 |
Why?
|
| Epitopes | 2 | 2016 | 328 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 3534 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2016 | 1062 | 0.120 |
Why?
|
| Cattle Diseases | 1 | 2015 | 20 | 0.120 |
Why?
|
| Reassortant Viruses | 1 | 2015 | 28 | 0.120 |
Why?
|
| Base Sequence | 4 | 2014 | 2783 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2014 | 590 | 0.110 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 40 | 0.110 |
Why?
|
| Biological Assay | 1 | 2015 | 108 | 0.110 |
Why?
|
| DNA, Viral | 2 | 1992 | 452 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 90 | 0.110 |
Why?
|
| Virus Attachment | 1 | 2014 | 32 | 0.110 |
Why?
|
| Viral Structural Proteins | 1 | 2014 | 39 | 0.100 |
Why?
|
| Bacteriophages | 1 | 2015 | 100 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 414 | 0.100 |
Why?
|
| Immunity, Mucosal | 3 | 2000 | 90 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 1994 | 787 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 511 | 0.100 |
Why?
|
| Genes, Viral | 2 | 1990 | 155 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1490 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 313 | 0.100 |
Why?
|
| Cell Line | 3 | 2016 | 2591 | 0.100 |
Why?
|
| Travel | 1 | 2014 | 130 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 194 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 2015 | 173 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2013 | 126 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 804 | 0.090 |
Why?
|
| Humans | 22 | 2024 | 132041 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2015 | 293 | 0.090 |
Why?
|
| Genotype | 3 | 2016 | 2655 | 0.090 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2010 | 13 | 0.080 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2010 | 53 | 0.080 |
Why?
|
| Fucosyltransferases | 1 | 2010 | 25 | 0.080 |
Why?
|
| Receptors, Chemokine | 1 | 2010 | 47 | 0.080 |
Why?
|
| ABO Blood-Group System | 1 | 2010 | 62 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2010 | 59 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 984 | 0.080 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 365 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 105 | 0.080 |
Why?
|
| Viral Tropism | 1 | 2010 | 48 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2010 | 116 | 0.080 |
Why?
|
| Calcium | 1 | 2014 | 1039 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 609 | 0.080 |
Why?
|
| Animals | 10 | 2015 | 34262 | 0.080 |
Why?
|
| Antibody Formation | 3 | 1999 | 232 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 817 | 0.070 |
Why?
|
| Rabbits | 5 | 1997 | 579 | 0.070 |
Why?
|
| Antibodies, Viral | 6 | 1997 | 1175 | 0.070 |
Why?
|
| Genome, Viral | 2 | 2024 | 159 | 0.070 |
Why?
|
| Administration, Oral | 3 | 1999 | 710 | 0.070 |
Why?
|
| Vaccines, Synthetic | 2 | 2000 | 319 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1270 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 112 | 0.060 |
Why?
|
| Drug Design | 1 | 2006 | 164 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 796 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 2148 | 0.050 |
Why?
|
| Glycomics | 2 | 2014 | 16 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2014 | 172 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 1019 | 0.050 |
Why?
|
| Adult | 5 | 2014 | 31747 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1320 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2006 | 814 | 0.040 |
Why?
|
| X-Ray Diffraction | 2 | 2014 | 100 | 0.040 |
Why?
|
| Dimerization | 2 | 2014 | 139 | 0.040 |
Why?
|
| Mice | 3 | 2010 | 18394 | 0.040 |
Why?
|
| Antibodies | 1 | 1999 | 323 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 424 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2016 | 59 | 0.030 |
Why?
|
| Hybridomas | 1 | 2016 | 30 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 106 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 248 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2014 | 18 | 0.030 |
Why?
|
| Interferometry | 1 | 2014 | 21 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2014 | 23 | 0.030 |
Why?
|
| Calorimetry | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 503 | 0.030 |
Why?
|
| Crystallography | 1 | 2014 | 38 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 61 | 0.030 |
Why?
|
| Virus Shedding | 1 | 1994 | 75 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 107 | 0.030 |
Why?
|
| DNA | 2 | 1990 | 1440 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 167 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2014 | 125 | 0.020 |
Why?
|
| Immunoassay | 1 | 2014 | 129 | 0.020 |
Why?
|
| Mexico | 1 | 2014 | 198 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2014 | 157 | 0.020 |
Why?
|
| Transplant Recipients | 1 | 2015 | 232 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1992 | 62 | 0.020 |
Why?
|
| Baculoviridae | 1 | 1992 | 41 | 0.020 |
Why?
|
| Graft Survival | 1 | 2015 | 466 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1992 | 37 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1992 | 71 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 283 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1994 | 956 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1992 | 201 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 315 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1236 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1990 | 73 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 26 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2015 | 564 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1990 | 316 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 299 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1990 | 227 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 456 | 0.020 |
Why?
|
| Male | 4 | 2015 | 65425 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2015 | 983 | 0.020 |
Why?
|
| Female | 4 | 2015 | 71380 | 0.020 |
Why?
|
| United States | 2 | 2015 | 11846 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1746 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 1398 | 0.020 |
Why?
|
| Time Factors | 1 | 1997 | 6283 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 93 | 0.020 |
Why?
|
| Virus Assembly | 1 | 2006 | 37 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2006 | 131 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2006 | 63 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 34 | 0.020 |
Why?
|
| Texas | 1 | 2015 | 3646 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2006 | 147 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1991 | 765 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 180 | 0.010 |
Why?
|
| Sulfones | 1 | 2006 | 73 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2006 | 286 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5287 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2006 | 161 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 194 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 4962 | 0.010 |
Why?
|
| Cryoelectron Microscopy | 1 | 2006 | 239 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 6539 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1148 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 612 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1991 | 4691 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 21018 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 11020 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 28946 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 28 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 1996 | 29 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1989 | 8613 | 0.010 |
Why?
|
| Child | 1 | 2015 | 26361 | 0.010 |
Why?
|
| Infant | 1 | 1989 | 13343 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1991 | 42 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 210 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 1093 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1988 | 282 | 0.000 |
Why?
|
| Age Factors | 1 | 1988 | 2868 | 0.000 |
Why?
|